Analysis of the novel factor X gene mutation Glu51Lys in two families with factor X-Riyadh anomaly

Summary Two families with 'factor X(FX)-Riyadh' have been identified (one of them related to the originally reported family). Affected members of both families exhibit prolongation in prothrombin time (PT) with normal partial thromboplastin time (PTT) and low assay levels of FX, when measu...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Thrombosis and haemostasis 2007-04, Vol.97 (4), p.542-545
Hauptverfasser: Akram Al-Hilali, Karin Wulff, Hikmat Abdel-Razeq, Khalida Abu Saud, Fateh Al-Gaili, Falko H. Herrmann
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 545
container_issue 4
container_start_page 542
container_title Thrombosis and haemostasis
container_volume 97
creator Akram Al-Hilali
Karin Wulff
Hikmat Abdel-Razeq
Khalida Abu Saud
Fateh Al-Gaili
Falko H. Herrmann
description Summary Two families with 'factor X(FX)-Riyadh' have been identified (one of them related to the originally reported family). Affected members of both families exhibit prolongation in prothrombin time (PT) with normal partial thromboplastin time (PTT) and low assay levels of FX, when measured by PT-based assay. They do not have clinical bleeding diathesis, regardless of the PT prolongation. FX genes of the affected family members were analyzed by sequence analysis. A novel missense mutation in exon 4 of the FX gene, which causes the Glu51Lys substitution in the first epidermal growth factor-like domain of FX was found. The Glu51Lys mutation represents a type II mutation with low FX coagulant activity in the extrinsic pathway and normal FX antigen levels. This mutation may result in disruption of the predicted H-bonding between residue Glu51 of FX and the Asn199 residue of the tissue factor (TF) in the FX/TF/factorVIIa ternary complex, producing the phenotype 'FX deficiency Riyadh', with prolonged PT and normal PTT.
doi_str_mv 10.1160/TH06-09-0532
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1160_TH06_09_0532</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>70325206</sourcerecordid><originalsourceid>FETCH-LOGICAL-c547t-f23f6d78f2c7d39e8a1946d1ab045a433745547ef28918933c2bab113ce93dd63</originalsourceid><addsrcrecordid>eNq1kcFrFDEUh4Modq3ePEtOXnQ0mUwyk2Mp2goLglToLWQyb0zKJFmTTJf9751hl3rSU3t6hPfl94PvIfSWkk-UCvL55pqIisiKcFY_Q5uai7YSnbx9jjaENaQSdcPP0Kuc7wihopH8JTqjLZOMUL5B_UXQ0yG7jOOIiwUc4j1MeNSmxIRv8S8IgP1cdHEx4Ktp5nR7yNgFXPZxwbybHGS8d8U-fKp-uIMeLNYh-iX8NXox6inDm9M8Rz-_frm5vK6236--XV5sK8ObtlRjzUYxtN1Ym3ZgEjpNZSMGqnvScN0w1jZ8AWGsO0k7yZipe91TygxINgyCnaP3x9xdir9nyEV5lw1Mkw4Q56xawmpekxX8eARNijknGNUuOa_TQVGiVqdqdaqIVKvTBX93yp17D8Nf-CRxAT4cgWIdeFB3cU6L1fyvOHeks7G6FD1DeogsNkXfx-UcSodBWQ0-5qLXt4mhQCjLIhnr7kG5nGdQLWuU12HOJrldUa2UQmUb98oWPy1d_hG78g6M09N_-8zT97E_NN37_Q</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>70325206</pqid></control><display><type>article</type><title>Analysis of the novel factor X gene mutation Glu51Lys in two families with factor X-Riyadh anomaly</title><source>MEDLINE</source><source>Thieme Connect Journals</source><creator>Akram Al-Hilali ; Karin Wulff ; Hikmat Abdel-Razeq ; Khalida Abu Saud ; Fateh Al-Gaili ; Falko H. Herrmann</creator><creatorcontrib>Akram Al-Hilali ; Karin Wulff ; Hikmat Abdel-Razeq ; Khalida Abu Saud ; Fateh Al-Gaili ; Falko H. Herrmann</creatorcontrib><description>Summary Two families with 'factor X(FX)-Riyadh' have been identified (one of them related to the originally reported family). Affected members of both families exhibit prolongation in prothrombin time (PT) with normal partial thromboplastin time (PTT) and low assay levels of FX, when measured by PT-based assay. They do not have clinical bleeding diathesis, regardless of the PT prolongation. FX genes of the affected family members were analyzed by sequence analysis. A novel missense mutation in exon 4 of the FX gene, which causes the Glu51Lys substitution in the first epidermal growth factor-like domain of FX was found. The Glu51Lys mutation represents a type II mutation with low FX coagulant activity in the extrinsic pathway and normal FX antigen levels. This mutation may result in disruption of the predicted H-bonding between residue Glu51 of FX and the Asn199 residue of the tissue factor (TF) in the FX/TF/factorVIIa ternary complex, producing the phenotype 'FX deficiency Riyadh', with prolonged PT and normal PTT.</description><identifier>ISSN: 0340-6245</identifier><identifier>EISSN: 2567-689X</identifier><identifier>DOI: 10.1160/TH06-09-0532</identifier><identifier>PMID: 17393015</identifier><language>eng</language><publisher>Germany: Schattauer Verlag für Medizin und Naturwissenschaften</publisher><subject>Adolescent ; Adult ; Aged ; Blood Coagulation, Fibrinolysis and Cellular Haemostasis ; Child ; DNA Mutational Analysis ; exon 4 ; Exons ; Factor X - genetics ; Factor X - metabolism ; Factor X Deficiency - blood ; Factor X Deficiency - genetics ; factor X-Riyadh ; Female ; Genotype ; Glutamic Acid ; Humans ; Lysine ; Male ; Middle Aged ; mutation ; Mutation, Missense ; Partial Thromboplastin Time ; Pedigree ; Phenotype ; Prothrombin Time ; Saudi Arabia</subject><ispartof>Thrombosis and haemostasis, 2007-04, Vol.97 (4), p.542-545</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c547t-f23f6d78f2c7d39e8a1946d1ab045a433745547ef28918933c2bab113ce93dd63</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.thieme-connect.de/products/ejournals/pdf/10.1160/TH06-09-0532.pdf$$EPDF$$P50$$Gthieme$$H</linktopdf><linktohtml>$$Uhttps://www.thieme-connect.de/products/ejournals/html/10.1160/TH06-09-0532$$EHTML$$P50$$Gthieme$$H</linktohtml><link.rule.ids>314,780,784,3016,27923,27924,54558,54559</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17393015$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Akram Al-Hilali</creatorcontrib><creatorcontrib>Karin Wulff</creatorcontrib><creatorcontrib>Hikmat Abdel-Razeq</creatorcontrib><creatorcontrib>Khalida Abu Saud</creatorcontrib><creatorcontrib>Fateh Al-Gaili</creatorcontrib><creatorcontrib>Falko H. Herrmann</creatorcontrib><title>Analysis of the novel factor X gene mutation Glu51Lys in two families with factor X-Riyadh anomaly</title><title>Thrombosis and haemostasis</title><addtitle>Thromb Haemost</addtitle><description>Summary Two families with 'factor X(FX)-Riyadh' have been identified (one of them related to the originally reported family). Affected members of both families exhibit prolongation in prothrombin time (PT) with normal partial thromboplastin time (PTT) and low assay levels of FX, when measured by PT-based assay. They do not have clinical bleeding diathesis, regardless of the PT prolongation. FX genes of the affected family members were analyzed by sequence analysis. A novel missense mutation in exon 4 of the FX gene, which causes the Glu51Lys substitution in the first epidermal growth factor-like domain of FX was found. The Glu51Lys mutation represents a type II mutation with low FX coagulant activity in the extrinsic pathway and normal FX antigen levels. This mutation may result in disruption of the predicted H-bonding between residue Glu51 of FX and the Asn199 residue of the tissue factor (TF) in the FX/TF/factorVIIa ternary complex, producing the phenotype 'FX deficiency Riyadh', with prolonged PT and normal PTT.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Blood Coagulation, Fibrinolysis and Cellular Haemostasis</subject><subject>Child</subject><subject>DNA Mutational Analysis</subject><subject>exon 4</subject><subject>Exons</subject><subject>Factor X - genetics</subject><subject>Factor X - metabolism</subject><subject>Factor X Deficiency - blood</subject><subject>Factor X Deficiency - genetics</subject><subject>factor X-Riyadh</subject><subject>Female</subject><subject>Genotype</subject><subject>Glutamic Acid</subject><subject>Humans</subject><subject>Lysine</subject><subject>Male</subject><subject>Middle Aged</subject><subject>mutation</subject><subject>Mutation, Missense</subject><subject>Partial Thromboplastin Time</subject><subject>Pedigree</subject><subject>Phenotype</subject><subject>Prothrombin Time</subject><subject>Saudi Arabia</subject><issn>0340-6245</issn><issn>2567-689X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNq1kcFrFDEUh4Modq3ePEtOXnQ0mUwyk2Mp2goLglToLWQyb0zKJFmTTJf9751hl3rSU3t6hPfl94PvIfSWkk-UCvL55pqIisiKcFY_Q5uai7YSnbx9jjaENaQSdcPP0Kuc7wihopH8JTqjLZOMUL5B_UXQ0yG7jOOIiwUc4j1MeNSmxIRv8S8IgP1cdHEx4Ktp5nR7yNgFXPZxwbybHGS8d8U-fKp-uIMeLNYh-iX8NXox6inDm9M8Rz-_frm5vK6236--XV5sK8ObtlRjzUYxtN1Ym3ZgEjpNZSMGqnvScN0w1jZ8AWGsO0k7yZipe91TygxINgyCnaP3x9xdir9nyEV5lw1Mkw4Q56xawmpekxX8eARNijknGNUuOa_TQVGiVqdqdaqIVKvTBX93yp17D8Nf-CRxAT4cgWIdeFB3cU6L1fyvOHeks7G6FD1DeogsNkXfx-UcSodBWQ0-5qLXt4mhQCjLIhnr7kG5nGdQLWuU12HOJrldUa2UQmUb98oWPy1d_hG78g6M09N_-8zT97E_NN37_Q</recordid><startdate>20070401</startdate><enddate>20070401</enddate><creator>Akram Al-Hilali</creator><creator>Karin Wulff</creator><creator>Hikmat Abdel-Razeq</creator><creator>Khalida Abu Saud</creator><creator>Fateh Al-Gaili</creator><creator>Falko H. Herrmann</creator><general>Schattauer Verlag für Medizin und Naturwissenschaften</general><general>Schattauer GmbH</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20070401</creationdate><title>Analysis of the novel factor X gene mutation Glu51Lys in two families with factor X-Riyadh anomaly</title><author>Akram Al-Hilali ; Karin Wulff ; Hikmat Abdel-Razeq ; Khalida Abu Saud ; Fateh Al-Gaili ; Falko H. Herrmann</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c547t-f23f6d78f2c7d39e8a1946d1ab045a433745547ef28918933c2bab113ce93dd63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Blood Coagulation, Fibrinolysis and Cellular Haemostasis</topic><topic>Child</topic><topic>DNA Mutational Analysis</topic><topic>exon 4</topic><topic>Exons</topic><topic>Factor X - genetics</topic><topic>Factor X - metabolism</topic><topic>Factor X Deficiency - blood</topic><topic>Factor X Deficiency - genetics</topic><topic>factor X-Riyadh</topic><topic>Female</topic><topic>Genotype</topic><topic>Glutamic Acid</topic><topic>Humans</topic><topic>Lysine</topic><topic>Male</topic><topic>Middle Aged</topic><topic>mutation</topic><topic>Mutation, Missense</topic><topic>Partial Thromboplastin Time</topic><topic>Pedigree</topic><topic>Phenotype</topic><topic>Prothrombin Time</topic><topic>Saudi Arabia</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Akram Al-Hilali</creatorcontrib><creatorcontrib>Karin Wulff</creatorcontrib><creatorcontrib>Hikmat Abdel-Razeq</creatorcontrib><creatorcontrib>Khalida Abu Saud</creatorcontrib><creatorcontrib>Fateh Al-Gaili</creatorcontrib><creatorcontrib>Falko H. Herrmann</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Thrombosis and haemostasis</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Akram Al-Hilali</au><au>Karin Wulff</au><au>Hikmat Abdel-Razeq</au><au>Khalida Abu Saud</au><au>Fateh Al-Gaili</au><au>Falko H. Herrmann</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Analysis of the novel factor X gene mutation Glu51Lys in two families with factor X-Riyadh anomaly</atitle><jtitle>Thrombosis and haemostasis</jtitle><addtitle>Thromb Haemost</addtitle><date>2007-04-01</date><risdate>2007</risdate><volume>97</volume><issue>4</issue><spage>542</spage><epage>545</epage><pages>542-545</pages><issn>0340-6245</issn><eissn>2567-689X</eissn><abstract>Summary Two families with 'factor X(FX)-Riyadh' have been identified (one of them related to the originally reported family). Affected members of both families exhibit prolongation in prothrombin time (PT) with normal partial thromboplastin time (PTT) and low assay levels of FX, when measured by PT-based assay. They do not have clinical bleeding diathesis, regardless of the PT prolongation. FX genes of the affected family members were analyzed by sequence analysis. A novel missense mutation in exon 4 of the FX gene, which causes the Glu51Lys substitution in the first epidermal growth factor-like domain of FX was found. The Glu51Lys mutation represents a type II mutation with low FX coagulant activity in the extrinsic pathway and normal FX antigen levels. This mutation may result in disruption of the predicted H-bonding between residue Glu51 of FX and the Asn199 residue of the tissue factor (TF) in the FX/TF/factorVIIa ternary complex, producing the phenotype 'FX deficiency Riyadh', with prolonged PT and normal PTT.</abstract><cop>Germany</cop><pub>Schattauer Verlag für Medizin und Naturwissenschaften</pub><pmid>17393015</pmid><doi>10.1160/TH06-09-0532</doi><tpages>4</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0340-6245
ispartof Thrombosis and haemostasis, 2007-04, Vol.97 (4), p.542-545
issn 0340-6245
2567-689X
language eng
recordid cdi_crossref_primary_10_1160_TH06_09_0532
source MEDLINE; Thieme Connect Journals
subjects Adolescent
Adult
Aged
Blood Coagulation, Fibrinolysis and Cellular Haemostasis
Child
DNA Mutational Analysis
exon 4
Exons
Factor X - genetics
Factor X - metabolism
Factor X Deficiency - blood
Factor X Deficiency - genetics
factor X-Riyadh
Female
Genotype
Glutamic Acid
Humans
Lysine
Male
Middle Aged
mutation
Mutation, Missense
Partial Thromboplastin Time
Pedigree
Phenotype
Prothrombin Time
Saudi Arabia
title Analysis of the novel factor X gene mutation Glu51Lys in two families with factor X-Riyadh anomaly
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T06%3A08%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Analysis%20of%20the%20novel%20factor%20X%20gene%20mutation%20Glu51Lys%20in%20two%20families%20with%20factor%20X-Riyadh%20anomaly&rft.jtitle=Thrombosis%20and%20haemostasis&rft.au=Akram%20Al-Hilali&rft.date=2007-04-01&rft.volume=97&rft.issue=4&rft.spage=542&rft.epage=545&rft.pages=542-545&rft.issn=0340-6245&rft.eissn=2567-689X&rft_id=info:doi/10.1160/TH06-09-0532&rft_dat=%3Cproquest_cross%3E70325206%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=70325206&rft_id=info:pmid/17393015&rfr_iscdi=true